UnknownNot Applicable

EUS-FNI for Nonfunctional Pancreatic Neuroendocrine Tumors

China20 participantsStarted 2018-09-28

Plain-language summary

The current study aims to access the feasibility, safety, and efficacy of EUS-FNI for nonfunctional pNETs

Age range18 Years – 85 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✕. Patients who are not suitable for EUS-FNI.
✕. Patients who have poor conditions including blood coagulation dysfunction, mental disorders, and mild or severe cardiorespiratory.

The rate of complete ablation

Timeframe: At 24 months after treatment

The Chang The change of tumor size

Timeframe: From baseline to 24 months

NCT IDNCT05566093

SponsorGuangxi Medical University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2025-12-31

Shanyu Qin, MD,Ph.D